CClinicalTrials.gg
CompletedNCT07261670VR-SADEUpdated Dec 3, 2025

A Comparative Study of Virtual Reality and Sensory-Adapted Dental Environments for Dental Anxiety Reduction in Individuals With BIF

An interventional study of Virtual Reality Distraction - immersive VR software delivered through Meta Quest 3® headset during dental procedure and Sensory adapted dentist environment in Borderline Intellectual Functioning (BIF), sponsored by Oasi Research Institute-IRCCS. Completed at 1 site in Italy. Open to participants aged 11 Years to 13 Years. Per ClinicalTrials.gov, last updated 2025-12-03.

Sponsored by Oasi Research Institute-IRCCS · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Jun 2025, registered Nov 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
98
Allocation
Randomized
Ages
11 Years to 13 Years
Sex
All
01

Study summary

A randomized clinical trial was conducted with 98 participants with borderline intellectual functioning (BIF) and moderate dental anxiety (DAS: 9-12). Participants were assigned in a 1:1 ratio to either the Virtual reality (VR) or sensory adapted dentist environment (SADE) group (49 per group). The primary outcome was treatment success, defined as completing a dental restoration under local anesthesia within 30 minutes.

02

Conditions studied

  • Borderline Intellectual Functioning (BIF)
03

In context

Lead sponsor

Oasi Research Institute-IRCCS is the lead sponsor of 8 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 13 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age of participants between 10 and 13 years
  • Diagnosis of Borderline Intellectual Func-tioning (BIF) confirmed by experienced neuropsychiatrists according to DSM-5 criteria
  • Moderate dental anxiety, defined by a DAS score between 9 and 12
  • Presence of at least one tooth with a Class I carious lesion requiring restorative treatment

Exclusion criteria

Exclusion Criteria:

  • absence of dental anxiety (DAS score = 4)
  • the presence of mild anxiety (DAS score = 5-8)
  • high or severe anxiety (DAS score ≥ 13)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
98 participants (actual)

Study arms

  • Experimental
    Virtual Reality Distraction

    immersive VR software delivered through Meta Quest 3® headset during dental procedure

    Device: Virtual Reality Distraction - immersive VR software delivered through Meta Quest 3® headset during dental procedure

  • Active comparator
    Sensory adapted dentist environment Control

    Sensory adapted dentist environment designed to reduce sensory stimuli with: * soft and dim lighting * a screen projecting familiar movies, cartoons, or videos previously provided by the family * a dental turbine handpiece covered with a sponge layer to minimize noise

    Device: Sensory adapted dentist environment

Interventions

  • DeviceVirtual Reality Distraction - immersive VR software delivered through Meta Quest 3® headset during dental procedure

    immersive VR software delivered through Meta Quest 3® headset during dental procedure

  • DeviceSensory adapted dentist environment

    Sensory adapted dentist environment designed to reduce sensory stimuli with: - soft and dim lighting - a screen projecting familiar movies, cartoons, or videos previously provided by the family - a dental turbine handpiece covered with a sponge layer to minimize noise

06

What researchers measure

Primary outcomes

  1. Treatment success

    Completion of restorative dental procedure under local anesthesia within 30 minutes and positive overall treatment experience (dichotomous: success vs. failure)

    Time frame: Duration of procedure

07

Study locations

1 site
  • IRCCS Ass. Oasi Maria SS
    Troina, EN 94018, Italy
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07261670
Lead sponsor
Oasi Research Institute-IRCCS
Responsible party
Sponsor
First posted
Dec 3, 2025
Start date
Jun 1, 2025
Primary completion
Sep 30, 2025
Completion
Sep 30, 2025
Last update
Dec 3, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion